This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Related letters  • Related article  • Similar articles in JAMA  Topic Collections  • Pediatrics  • Adolescent Medicine  • Psychiatry  • Depression  • Randomized Controlled Trial  • Drug Therapy  • Adverse Effects  • Alert me on articles by topic  Social Bookmarking   What's this?

Treatment for Adolescents With Depression Study (TADS) Randomized Controlled Trial

Treatment for Adolescents With Depression Study (TADS) Team

JAMA. 2004;292:807-820.

Context  Initial treatment of major depressive disorder in adolescents may include cognitive-behavioral therapy (CBT) or a selective serotonin reuptake inhibitor (SSRI). However, little is known about their relative or combined effectiveness.

Objective  To evaluate the effectiveness of 4 treatments among adolescents with major depressive disorder.

Design, Setting, and Participants  Randomized controlled trial of a volunteer sample of 439 patients between the ages of 12 to 17 years with a primary Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, diagnosis of major depressive disorder. The trial was conducted at 13 US academic and community clinics between spring 2000 and summer 2003.

Interventions  Twelve weeks of (1) fluoxetine alone (10 to 40 mg/d), (2) CBT alone, (3) CBT with fluoxetine (10 to 40 mg/d), or (4) placebo (equivalent to 10 to 40 mg/d). Placebo and fluoxetine alone were administered double-blind; CBT alone and CBT with fluoxetine were administered unblinded.

Main Outcome Measures  Children's Depression Rating Scale-Revised total score and, for responder analysis, a (dichotomized) Clinical Global Impressions improvement score.

Results  Compared with placebo, the combination of fluoxetine with CBT was statistically significant (P = .001) on the Children's Depression Rating Scale-Revised. Compared with fluoxetine alone (P = .02) and CBT alone (P = .01), treatment of fluoxetine with CBT was superior. Fluoxetine alone is a superior treatment to CBT alone (P = .01). Rates of response for fluoxetine with CBT were 71.0% (95% confidence interval [CI], 62%-80%); fluoxetine alone, 60.6% (95% CI, 51%-70%); CBT alone, 43.2% (95% CI, 34%-52%); and placebo, 34.8% (95% CI, 26%-44%). On the Clinical Global Impressions improvement responder analysis, the 2 fluoxetine-containing conditions were statistically superior to CBT and to placebo. Clinically significant suicidal thinking, which was present in 29% of the sample at baseline, improved significantly in all 4 treatment groups. Fluoxetine with CBT showed the greatest reduction (P = .02). Seven (1.6%) of 439 patients attempted suicide; there were no completed suicides.

Conclusion  The combination of fluoxetine with CBT offered the most favorable tradeoff between benefit and risk for adolescents with major depressive disorder.

Authors/Treatment for Adolescents With Depression Study (TADS) Team Coordinating Center: John March, Susan Silva, Stephen Petrycki, John Curry, Karen Wells, John Fairbank, Barbara Burns, Marisa Domino, and Steven McNulty, clinical coordinating center, Duke Clinical Research Institute, Duke University Medical Center, Durham, NC; Benedetto Vitiello, Joanne Severe, National Institute of Mental Health, Rockville, Md.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED LETTERS

Tailoring Treatment to Parental Values: A Comment on TADS

Arch Gen Psychiatry. ;65():723-723.
FULL TEXT  

Tailoring Treatment to Parental Values: A Comment on TADS--Reply
and
Arch Gen Psychiatry. ;65():723-724.
FULL TEXT  

Adolescents With Depression
and
JAMA. ;292():2577-2577.
FULL TEXT  

Adolescents With Depression
and
JAMA. ;292():2577-2578.
FULL TEXT  

Adolescents With Depression

JAMA. ;292():2578-2578.
FULL TEXT  

Adolescents With Depression
and
JAMA. ;292():2578-2578.
FULL TEXT  

Adolescents With Depression--Reply

JAMA. ;292():2578-2579.
FULL TEXT  

RELATED ARTICLE

Treatment of Adolescents With Major Depression: Contributions of a Major Trial

JAMA. ;292():861-863.
FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Introduction to the STAR*D Special Section
Norquist
Psychiatr. Serv. 2009;60:1437-1438.
FULL TEXT  

Clinical Messages From the Treatment for Adolescents With Depression Study (TADS)
March and Vitiello
Am. J. Psychiatry 2009;166:1118-1123.
ABSTRACT | FULL TEXT  

The Treatment for Adolescents With Depression Study (TADS): Outcomes Over 1 Year of Naturalistic Follow-Up
Treatment for Adolescents With Depression Study (T
Am. J. Psychiatry 2009;166:1141-1149.
ABSTRACT | FULL TEXT  

Treatment of Youth Depression
Campo and Bridge
Am. J. Psychiatry 2009;166:958-960.
FULL TEXT  

Long-Term Benefits of Short-Term Quality Improvement Interventions for Depressed Youths in Primary Care
Asarnow et al.
Am. J. Psychiatry 2009;166:1002-1010.
ABSTRACT | FULL TEXT  

Impact of Multifamily Psychoeducational Psychotherapy in Treating Children Aged 8 to 12 Years With Mood Disorders
Fristad et al.
Arch Gen Psychiatry 2009;66:1013-1021.
ABSTRACT | FULL TEXT  

Prevention of Depression in At-Risk Adolescents: A Randomized Controlled Trial
Garber et al.
JAMA 2009;301:2215-2224.
ABSTRACT | FULL TEXT  

School-Based Cognitive-Behavioral Therapy for Adolescent Depression: A Benchmarking Study
Shirk et al.
Journal of Emotional and Behavioral Disorders 2009;17:106-117.
ABSTRACT  

Depression and Suicide in Children and Adolescents
Prager
Pediatr. Rev. 2009;30:199-206.
FULL TEXT  

Mind Over Medicine: the Influence of Expectations on Antidepressant Response
Rutherford et al.
J Am Psychoanal Assoc 2009;57:456-460.
 

Screening and Treatment for Major Depressive Disorder in Children and Adolescents: US Preventive Services Task Force Recommendation Statement
US Preventive Services Task Force
Pediatrics 2009;123:1223-1228.
ABSTRACT | FULL TEXT  

Screening for Child and Adolescent Depression in Primary Care Settings: A Systematic Evidence Review for the US Preventive Services Task Force
Williams et al.
Pediatrics 2009;123:e716-e735.
ABSTRACT | FULL TEXT  

Assessment of Safety and Long-Term Outcomes of Initial Treatment With Placebo in TADS
Kennard et al.
Am. J. Psychiatry 2009;166:337-344.
ABSTRACT | FULL TEXT  

Placebo Response in Randomized Controlled Trials of Antidepressants for Pediatric Major Depressive Disorder
Bridge et al.
Am. J. Psychiatry 2009;166:42-49.
ABSTRACT | FULL TEXT  

Core Components of Therapy in Youth: Do We Know what to Disseminate?
Weersing et al.
Behav Modif 2009;33:24-47.
ABSTRACT  

Exercise in the Prevention and Treatment of Adolescent Depression: A Promising but Little Researched Intervention
Dunn and Weintraub
AMERICAN JOURNAL OF LIFESTYLE MEDICINE 2008;2:507-518.
ABSTRACT  

Predicting Future Risk of Depressive Episode in Adolescents: The Chicago Adolescent Depression Risk Assessment (CADRA)
Van Voorhees et al.
Ann Fam Med 2008;6:503-511.
ABSTRACT | FULL TEXT  

Treatment for Adolescents with Depression Study (TADS)
Vitiello
BMJ 2008;337:a2070-a2070.
FULL TEXT  

The ethics of paediatric anti-depressant use: erring on the side of caution
Shearer and Bermingham
J. Med. Ethics 2008;34:710-714.
ABSTRACT | FULL TEXT  

Dr. Emslie Replies
EMSLIE
Am. J. Psychiatry 2008;165:1205-1205.
FULL TEXT  

Truly independent research?
Lenzer
BMJ 2008;337:a1332-a1332.
FULL TEXT  

Patient Management Exercise Child and Adolescent Psychiatry
Levine and Albucher
Focus 2008;6:299-313.
ABSTRACT | FULL TEXT  

Fluoxetine Versus Placebo in Preventing Relapse of Major Depression in Children and Adolescents
Emslie et al.
Focus 2008;6:348-357.
ABSTRACT | FULL TEXT  

Practice Parameter for the Assessment and Treatment of Children and Adolescents With Depressive Disorders
Focus 2008;6:379-400.
ABSTRACT | FULL TEXT  

Efficacy of antidepressants in juvenile depression: meta-analysis
Tsapakis* et al.
Br. J. Psychiatry 2008;193:10-17.
ABSTRACT | FULL TEXT  

Use and misuse of drugs and alcohol in adolescence
McArdle
BMJ 2008;337:a306-a306.
FULL TEXT  

Tailoring Treatment to Parental Values: A Comment on TADS
Antonuccio
Arch Gen Psychiatry 2008;65:723-723.
FULL TEXT  

Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2000 British Association for Psychopharmacology guidelines
Anderson et al.
J Psychopharmacol 2008;22:343-396.
ABSTRACT  

Tailoring Treatment to Parental Values: A Comment on TADS--Reply
March and for the TADS Team
Arch Gen Psychiatry 2008;65:723-724.
FULL TEXT  

Alcohol abuse in adolescents
McArdle
Arch. Dis. Child. 2008;93:524-527.
ABSTRACT | FULL TEXT  

Cost-Effectiveness of Depression Treatment for Adolescents
Norquist et al.
Am. J. Psychiatry 2008;165:549-552.
FULL TEXT  

Cost-Effectiveness of Treatments for Adolescent Depression: Results From TADS
Domino et al.
Am. J. Psychiatry 2008;165:588-596.
ABSTRACT | FULL TEXT  

Continuation Treatment With Antidepressants in Child and Adolescent Major Depression
Ryan
Am. J. Psychiatry 2008;165:411-412.
FULL TEXT  

Fluoxetine Versus Placebo in Preventing Relapse of Major Depression in Children and Adolescents
Emslie et al.
Am. J. Psychiatry 2008;165:459-467.
ABSTRACT | FULL TEXT  

Achievement and Maintenance of Sustained Response During the Treatment for Adolescents With Depression Study Continuation and Maintenance Therapy
Rohde et al.
Arch Gen Psychiatry 2008;65:447-455.
ABSTRACT | FULL TEXT  

Perplexed trainees - what do you follow: the NICE guidelines or clinical wisdom?
Pemmaraju and Hvidsten
Psychiatr. Bull. 2008;32:156-156.
FULL TEXT  

A Depressed Adolescent at High Risk of Suicidal Behavior
Vitiello and Pearson
Am. J. Psychiatry 2008;165:323-328.
FULL TEXT  

Use of Selective Serotonin Reuptake Inhibitors by Pediatricians: Comparing Attitudes of Primary Care Pediatricians and Child and Adolescent Psychiatrists
Heneghan et al.
CLIN PEDIATR 2008;47:148-154.
ABSTRACT  

Switching to Another SSRI or to Venlafaxine With or Without Cognitive Behavioral Therapy for Adolescents With SSRI-Resistant Depression: The TORDIA Randomized Controlled Trial
Brent et al.
JAMA 2008;299:901-913.
ABSTRACT | FULL TEXT  

CBT plus an SSRI was as effective as an SSRI alone for adolescents with moderate to severe depression.
Kutcher
Evid. Based Med. 2008;13:13-13.
FULL TEXT  

Uncritical positive regard? Issues in the efficacy and safety of psychotherapy
Nutt and Sharpe
J Psychopharmacol 2008;22:3-6.
 

Cognitive-Behavioral Interventions to Reduce Suicide Behavior: A Systematic Review and Meta-Analysis
Tarrier et al.
Behav Modif 2008;32:77-108.
ABSTRACT  

Effects of Food and Drug Administration Warnings on Antidepressant Use in a National Sample
Olfson et al.
Arch Gen Psychiatry 2008;65:94-101.
ABSTRACT | FULL TEXT  

Child psychiatry and its relationship with the pharmaceutical industry: theoretical and practical issues
Timimi
Adv. Psychiatr. Treat. 2008;14:3-9.
ABSTRACT | FULL TEXT  

Pharmacotherapy and child psychiatry: is there a way forward?: INVITED COMMENTARY ON... CHILD PSYCHIATRY AND ITS RELATIONSHIP WITH THE PHARMACEUTICAL INDUSTRY
James
Adv. Psychiatr. Treat. 2008;14:10-16.
ABSTRACT | FULL TEXT  

A Randomized Controlled Trial of Fluoxetine and Cognitive Behavioral Therapy in Adolescents With Major Depression, Behavior Problems, and Substance Use Disorders
Riggs et al.
Arch Pediatr Adolesc Med 2007;161:1026-1034.
ABSTRACT | FULL TEXT  

Guidelines for Adolescent Depression in Primary Care (GLAD-PC): II. Treatment and Ongoing Management
Cheung et al.
Pediatrics 2007;120:e1313-e1326.
ABSTRACT | FULL TEXT  

Should young people be given antidepressants? Yes
Cotgrove
BMJ 2007;335:750-750.
FULL TEXT  

Should young people be given antidepressants? No
Timimi
BMJ 2007;335:751-751.
FULL TEXT  

The Treatment for Adolescents With Depression Study (TADS): Long-term Effectiveness and Safety Outcomes
The TADS Team
Arch Gen Psychiatry 2007;64:1132-1143.
ABSTRACT | FULL TEXT  

NICE guidelines on depression in children and young people: not always following the evidence
Hodes and Garralda
Psychiatr. Bull. 2007;31:361-362.
FULL TEXT  

Suicide and Suicide Attempts in Adolescents
Shain and and the Committee on Adolescence
Pediatrics 2007;120:669-676.
ABSTRACT | FULL TEXT  

Is depression overdiagnosed? No
Hickie
BMJ 2007;335:329-329.
FULL TEXT  

Combined fluoxetine plus cognitive behavioural therapy is more effective than monotherapy or placebo for adolescents with depression
Zuckerbrot
Evid. Based Ment. Health 2007;10:84-84.
FULL TEXT  

Cognitive behavioural therapy plus fluoxetine offers some safety advantages over fluoxetine alone in adolescents with depression
Dubicka
Evid. Based Ment. Health 2007;10:85-85.
FULL TEXT  

Depression in adolescents
Hazell
BMJ 2007;335:106-107.
FULL TEXT  

Selective serotonin reuptake inhibitors (SSRIs) and routine specialist care with and without cognitive behaviour therapy in adolescents with major depression: randomised controlled trial
Goodyer et al.
BMJ 2007;335:142-142.
ABSTRACT | FULL TEXT  

Effect of Regulatory Warnings on Antidepressant Prescribing for Children and Adolescents
Kurian et al.
Arch Pediatr Adolesc Med 2007;161:690-696.
ABSTRACT | FULL TEXT  

The FDA Pediatric Advisories and Changes in Diagnosis and Treatment of Pediatric Depression
Pfeffer
Am. J. Psychiatry 2007;164:843-846.
FULL TEXT  

Differential Effects of the Tricyclic Antidepressant Desipramine on the Density of Adrenergic Receptors in Juvenile and Adult Rats
Deupree et al.
J. Pharmacol. Exp. Ther. 2007;321:770-776.
ABSTRACT | FULL TEXT  

Clinical Response and Risk for Reported Suicidal Ideation and Suicide Attempts in Pediatric Antidepressant Treatment: A Meta-analysis of Randomized Controlled Trials
Bridge et al.
JAMA 2007;297:1683-1696.
ABSTRACT | FULL TEXT  

Impact of the FDA Black Box Warning on Physician Antidepressant Prescribing and Practice Patterns: Opening Pandora's Suicide Box
Lineberry et al.
Mayo Clin Proc. 2007;82:518-520.
FULL TEXT  

Application of Behavioral Activation Treatment for Depression to an Adolescent With a History of Child Maltreatment
Ruggiero et al.
Clinical Case Studies 2007;6:64-78.
ABSTRACT  

Restrictions on Antidepressant Medications for Children: A Review of Medicaid Policy
Fischer et al.
Psychiatr. Serv. 2007;58:135-138.
ABSTRACT | FULL TEXT  

Adolescent Depression Screening in Primary Care: Feasibility and Acceptability
Zuckerbrot et al.
Pediatrics 2007;119:101-108.
ABSTRACT | FULL TEXT  

Clinical trials bureaucracy: unintended consequences of well-intentioned policy
Califf
Clin Trials 2006;3:496-502.
ABSTRACT  

Suicidal behaviour in youths with depression treated with new-generation antidepressants: Meta-analysis
DUBICKA et al.
Br. J. Psychiatry 2006;189:393-398.
ABSTRACT | FULL TEXT  

US Suicide Rates by Age Group, 1970-2002: An Examination of Recent Trends
McKeown et al.
AJPH 2006;96:1744-1751.
ABSTRACT | FULL TEXT  

Bibliography PSYCHOPHARMACOLOGY
Focus 2006;4:512.
FULL TEXT  

Should Selective Serotonin Reuptake Inhibitors Be Prescribed for Children With Major Depressive and Anxiety Disorders?
Safer
Pediatrics 2006;118:1248-1251.
FULL TEXT  

Co-occurring Psychiatric Disorders in Children and Adolescents With Tourette Syndrome
Gaze et al.
J Child Neurol 2006;21:657-664.
ABSTRACT  

Antidepressant drug therapy and suicide in severely depressed children and adults: a case-control study.
Olfson et al.
Arch Gen Psychiatry 2006;63:865-872.
ABSTRACT | FULL TEXT  

Enhancing the efficacy of antidepressants with psychotherapy
Petersen
J Psychopharmacol 2006;20:19-28.
ABSTRACT  

Do antidepressants cause suicidality in children? A Bayesian meta-analysis
Kaizar et al.
Clin Trials 2006;3:73-98.
ABSTRACT  

Suicidal risk in antidepressant drug trials.
Baldessarini et al.
Arch Gen Psychiatry 2006;63:246-248.
FULL TEXT  

Suicidality in pediatric patients treated with antidepressant drugs.
Hammad et al.
Arch Gen Psychiatry 2006;63:332-339.
ABSTRACT | FULL TEXT  

Recognizing and treating depression in children and adolescents
Dopheide
Am J Health Syst Pharm 2006;63:233-243.
ABSTRACT | FULL TEXT  

The use of antidepressants to treat depression in children and adolescents
Cheung et al.
CMAJ 2006;174:193-200.
ABSTRACT | FULL TEXT  

Depression in Children and Adolescents
Davis
The Journal of School Nursing 2005;21:311-317.
ABSTRACT | FULL TEXT  

The medical management of depression.
Mann
NEJM 2005;353:1819-1834.
FULL TEXT  

Wishful thinking: antidepressant drugs in childhood depression
TONKIN and JUREIDINI
Br. J. Psychiatry 2005;187:304-305.
FULL TEXT  

Pharmacologic Response to Depressive Disorders Among Adolescents
Sewitch et al.
Psychiatr. Serv. 2005;56:1089-1097.
ABSTRACT | FULL TEXT  

Longitudinal Antiretroviral Adherence Among Adolescents Infected With Human Immunodeficiency Virus
Murphy et al.
Arch Pediatr Adolesc Med 2005;159:764-770.
ABSTRACT | FULL TEXT  

The Food and Drug Administration's Deliberations on Antidepressant Use in Pediatric Patients
Leslie et al.
Pediatrics 2005;116:195-204.
ABSTRACT | FULL TEXT  

Antidepressants and Children's Depression
DILLER
Am. J. Psychiatry 2005;162:1226-1227.
FULL TEXT  

Continuing fluoxetine treatment may delay relapse in children and adolescents with major depressive disorder
Wilkinson
Evid. Based Ment. Health 2005;8:37-37.
FULL TEXT  

Suicidality in pre-adolescence and early adulthood is associated with psychosocial and psychiatric problems in young adulthood
Beautrais
Evid. Based Ment. Health 2005;8:48-48.
FULL TEXT  

Should we prescribe antidepressants to children?
Dubicka and Goodyer
Psychiatr. Bull. 2005;29:164-167.
FULL TEXT  

Toward a Neurobiology of Psychotherapy: Basic Science and Clinical Applications
Etkin et al.
J. Neuropsychiatry Clin. Neurosi. 2005;17:145-158.
ABSTRACT | FULL TEXT  

Selective serotonin-reuptake inhibitors and suicidal ideation and behavior in children
Caballero and Nahata
Am J Health Syst Pharm 2005;62:864-867.
FULL TEXT  

Fluoxetine plus cognitive behavioural therapy was most effective for adolescents with major depressive disorder
Dubicka and Ramchandani
Evid. Based Med. 2005;10:46-46.
FULL TEXT  

Fluoxetine plus cognitive behavioural therapy was most effective for adolescents with major depressive disorder
Rew
Evid. Based Nurs. 2005;8:45-45.
FULL TEXT  

Authors of TADS study reply to letter raising concerns
March and for the TADS Group
BMJ 2005;330:730-731.
FULL TEXT  

Death by tricyclic: the real antidepressant scandal?
Nutt
J Psychopharmacol 2005;19:123-124.
 

Rethinking childhood depression: Does childhood depression exist?
Double
BMJ 2005;330:418-418.
FULL TEXT  

Fluoxetine plus cognitive behavioural therapy improves symptoms of major depressive disorder in adolescents
Leon
Evid. Based Ment. Health 2005;8:10-10.
FULL TEXT